
Advancing Generic Drug Development:
Modernizing Bioequivalence Approaches for
Topical & Transdermal Products
September 10, 2026
Click Here for Details
Agenda & Speaker Bios

Event Agenda
The event agenda is still being refined and may be updated over time. The current version is v4, uploaded on August 4, 2026.

Speaker Biographies
The speaker biographies document provides detailed information for each of the event presenters. The speaker biographies document is still being refined and may be updated over time.
Files & Recordings
Download Presentation Slides
Download Presentation Slides
Session Evaluations
- Current Recommendations and ANDA Landscape for Topical Products – Tannaz Ramezanli
- ANDA Assessment Challenges for IVPT Studies – Bioequivalence Perspective – Allison Schafer
- Mechanistic Modeling to Support the Approval of Generic Tazarotene Cream – Eleftheria Tsakalozou
- Critical Formulation, Foam-Structure, and Performance Attributes of Topical Foams -Ahmed Zidan
- IVPT Unplugged: From Challenges to Solutions in Topical Permeation Method Development – Nahid Kamal
- Mechanistic Modelling to Streamline PSG Recommendations and Reduce Regulatory Burden – Eleftheria Tsakalozou
- Current Recommendations and ANDA Landscape for TDS – Ying Jiang
Event Evaluation & Certificate
Evaluation and Certificate
Session Recordings
Recordings will be linked here as soon as they are available.
Questions & More Information
Continuing Education
Real-time attendance is required for the certificate of attendance which can be used in support of CEs for the following professional organizations.
Certificates are only available during the two weeks post-event (until September 24, 2026).
This event has been pre-approved by:
- RAPS as eligible for a maximum of 12 credits for a two-day event (appropriate to real-time attendance) towards a participant’s RAC recertification upon full completion.
- SOCRA who accepts documentation of candidate participation in continuing education programs for re-certification if the program is applicable to clinical research regulations, operations or management, or to the candidate’s clinical research therapeutic area.
- SQA as eligible for 1 non-GCP or non-GLP unit for every 1 hour of instructional time towards a participant’s RQAP re-registration.
- ACRP for continuing education in clinical research. ACRP will provide 1 ACRP contact hour for every 45-60 minutes of qualified material.
Questions?
Please refer the FAQs page on this website. If you are not able to find your answer there, please email us at info@sbiaevents.com.
If you have questions regarding the content of the event or other CDER-specific information, please:
- Visit the CDER SBIA website
- Learn more about CDER SBIA Workshops and Webinars
- Subscribe to the CDER SBIA email updates
- Follow us on LinkedIn